NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Belinson S, Chopra R, Yang Y, et al. Local Hepatic Therapies for Metastases to the Liver From Unresectable Colorectal Cancer [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Dec. (Comparative Effectiveness Reviews, No. 93.)
This publication is provided for historical reference only and the information may be out of date.
Local Hepatic Therapies for Metastases to the Liver From Unresectable Colorectal Cancer [Internet].
Show detailsTable D-1List of authors contacted with questions during this review and the question resolution
| Author | Response from Authors Sufficient for Issue Resolution | Question/Resolution |
|---|---|---|
| Chua - 20101 | Yes | Time from which survival is measured?/Measured from date of RE to date of death or last FU |
| Albert – 20112 | No | Need to determine number of patients received 0 lines of previous systemic chemotherapy/None |
| Hendlisz – 20103 | Yes | Need to clarify why patients were given further chemotherapy/Chemotherapy given for disease progression. Include study and use time to liver progression statistics. |
| Meijerink - 20114 | No | Uncertain if patients were refractory to chemotherapy./Study excluded due to small sample size and potential contamination. |
| Stintzing – 20115 | Yes | Did any of the CRC liver mets. Patients refuse treatment?/None of these patients refused treatment |
| Vautravers-Dewas - 20116 | No | Uncertain about extrahepatic metastases in patients./None |
| Murthy - 20077 | No | Uncertain about treatment dates for this study/None |
| Ritz – 20078 | No | Uncertain if patients are refractory/None |
| Martin – 20119 | No | Do survival statistics correspond to complete responders alone?/No response but study included and assumed that issue resulted from a typographical error in table creation. |
| Tsutsumi - 200810 | No | Article does not give survival starting point/None |
| Cianni – 200911 | Yes | Article does not give survival starting point, potential overlap in study populations/Author clarified that this was from time of treatment and that this was not a duplicated patient population. |
| Hong - 200912 | No | Discrepancy in table statistics/none |
| Lim - 200513 | Yes | Article does not give survival starting point/Author clarified that this was from study treatment. |
| Fiorentini – 200714 | No | Article does not give survival starting point/None |
- 1.
- Chua TC, Bester L, Akther J, et al. Successful right hepatectomy after four treatments of yttrium-90 microspheres (SIR-Spheres) and concomitant FOLFOX as bridging therapy to resection of colorectal liver metastases. Anticancer Res. 2010 Jul;30(7):3005–7. [PubMed: 20683046]
- 2.
- Albert M, Kiefer MV, Sun W, et al. Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol. Cancer. 2011 Jan 15;117(2):343–52. [PubMed: 20830766]
- 3.
- Hendlisz A, Van den Eynde M, Peeters M, et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol. 2010 Aug 10;28(23):3687–94. [PubMed: 20567019]
- 4.
- Meijerink MR, van den Tol P, van Tilborg AA, et al. Radiofrequency ablation of large size liver tumours using novel plan-parallel expandable bipolar electrodes: initial clinical experience. Eur J Radiol. 2011 Jan;77(1):167–71. [PubMed: 19616911]
- 5.
- Stintzing S, Hoffmann RT, Heinemann V, et al. Frameless single-session robotic radiosurgery of liver metastases in colorectal cancer patients. Eur J Cancer. 2010 Apr;46(6):1026–32. [PubMed: 20153959]
- 6.
- Vautravers-Dewas C, Dewas S, Bonodeau F, et al. Image-guided robotic stereotactic body radiation therapy for liver metastases: Is there a dose response relationship? Int J Radiat Oncol Biol Phys. 2011 Mar 4 [PubMed: 21377292]
- 7.
- Murthy R, Eng C, Krishnan S, et al. Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. J Vasc Interv Radiol. 2007 Dec;18(12):1588–91. [PubMed: 18057297]
- 8.
- Ritz JP, Lehmann KS, Reissfelder C, et al. Bipolar radiofrequency ablation of liver metastases during laparotomy. First clinical experiences with a new multipolar ablation concept. Int J Colorectal Dis. 2006 Jan;21(1):25–32. [PubMed: 15875202]
- 9.
- Martin RC, Joshi J, Robbins K, et al. Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study. Ann Surg Oncol. 2011 Jan;18(1):192–8. [PubMed: 20740319]
- 10.
- Tsutsumi S, Yamaguchi S, Tsuboi K, et al. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer. Hepatogastroenterology. 2008 Jul-Aug;55(85):1419–22. [PubMed: 18795703]
- 11.
- Cianni R, Urigo C, Notarianni E, et al. Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases. Cardiovasc Intervent Radiol. 2009 Nov;32(6):1179–86. [PubMed: 19680720]
- 12.
- Hong K, McBride JD, Georgiades CS, et al. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol. 2009 Mar;20(3):360–7. [PubMed: 19167245]
- 13.
- Lim L, Gibbs P, Yip D, et al. A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy. BMC Cancer. 2005;5:132. [PMC free article: PMC1274303] [PubMed: 16225697]
- 14.
- Fiorentini G, Aliberti C, Turrisi G, et al. Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: Results of a phase II clinical study. In Vivo. 2007;21(6):1085–92. [PubMed: 18210761]
- Contacted Authors - Local Hepatic Therapies for Metastases to the Liver From Unr...Contacted Authors - Local Hepatic Therapies for Metastases to the Liver From Unresectable Colorectal Cancer
- Executive Summary - Medication Therapy Management Interventions in Outpatient Se...Executive Summary - Medication Therapy Management Interventions in Outpatient Settings
- orphan G-protein coupled receptor GPR72 [Homo sapiens]orphan G-protein coupled receptor GPR72 [Homo sapiens]gi|7248882|gb|AAF43705.1|AF236081_1Protein
- Excluded Studies - Multidisciplinary Postacute Rehabilitation for Moderate to Se...Excluded Studies - Multidisciplinary Postacute Rehabilitation for Moderate to Severe Traumatic Brain Injury in Adults
- Lrrc3c leucine rich repeat containing 3C [Mus musculus]Lrrc3c leucine rich repeat containing 3C [Mus musculus]Gene ID:192852Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...